South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market Regional Analysis

6.2 South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue 2018-2028 (US$ Million)

6.3 South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast Analysis

7. South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market Analysis – by Diagnosis

7.1 Laboratory Tests

7.1.1 Overview
7.1.2 Laboratory Tests: South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast, 2018-2028 (US$ Million)

7.2 Imaging Tests

7.2.1 Overview
7.2.2 Imaging Tests: South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast, 2018-2028 (US$ Million)

8. South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market Analysis – by Indication

8.1 Pain & Cramping

8.1.1 Overview
8.1.2 Pain & Cramping: South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast, 2018-2028 (US$ Million)

8.2 Diarrhea

8.2.1 Overview
8.2.2 Diarrhea: South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast, 2018-2028 (US$ Million)

8.3 Constipation

8.3.1 Overview
8.3.2 Constipation: South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast, 2018-2028 (US$ Million)

8.4 Alternating Constipation & Diarrhea

8.4.1 Overview
8.4.2 Alternating Constipation & Diarrhea : South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast, 2018-2028 (US$ Million)

9. South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market – South and Central America Analysis

9.1 Overview

9.2 South and Central America

9.2.1 South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Key Country, 2021 and 2028 (%)
9.2.1.1 South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast Analysis – by Country
9.2.1.1 Brazil: South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.1.1 Brazil: South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Diagnosis
9.2.1.1.2 Brazil: South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Indication

9.2.1.2 Argentina: South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.2.1 Argentina: South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Diagnosis
9.2.1.2.2 Argentina: South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Indication

9.2.1.3 Rest of South and Central America : South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.3.1 Rest of South and Central America : South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Diagnosis
9.2.1.3.2 Rest of South and Central America : South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Indication

10. Competitive Landscape

10.1 Heat Map Analysis

10.2 Company Positioning and Concentration

11. Industry Landscape

11.1 Overview

11.2 Market Initiative

11.3 Partnerships and Collaborations

11.4 Other Developments

12. Company Profiles

12.1 Commonwealth Diagnostics International

12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments

12.2 Genova Diagnostics

12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments

12.3 Inova Diagnostics, Inc

12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments

12.4 Biohit Oyj

12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments

12.5 Aerodiagnostics, LLC.

12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

12.6 Sysmex Corporation (Sysmex Europe GmbH)

12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments

13. Appendix

13.1 About Business Market Insights

13.2 List of Abbreviations

South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market

Analysis By Diagnosis (Laboratory Tests, and Imaging Tests), and Indication (Pain & Cramping, Diarrhea, Constipation, and Alternating Constipation & Diarrhea)